Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Evoke Pharma Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 23 | 25 | +2 |
| Shares | 4.20M | 2.05M | −2.16M (−51.3%) |
| Value | $5.46M | $1.13M | −$4.33M (−79.3%) |
New holders (5)
Institutions that held Evoke Pharma Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 45,535 | $25.0K | 0.00% |
| Jane Street Group, LLC | 14,775 | $8.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,157 | $2.00K | 0.00% |
| Simplex Trading, LLC | 2,342 | $1.00K | 0.00% |
| Bank of America Corp | 48 | $0 | 0.00% |
Sold out (3)
Institutions that held Evoke Pharma Inc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| AIGH Capital Management LLC | 1,701,185 | $2.21M |
| Worth Venture Partners, LLC | 397,742 | $517.0K |
| Two Sigma Securities, LLC | 16,131 | $21.0K |